LEXINGTON, Mass. and AMSTERDAM, May 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...
BIRMINGHAM, AL, UNITED STATES, January 8, 2026 / EINPresswire.com / — Rampart, a Birmingham, Alabama–based medical device ...
Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...
A peripheral IV was placed, and the patient was connected to a cardiac monitor, which showed atrial fibrillation and a heart rate of 70 beats/minute, which is a rare presentation but could be ...
Credit: Getty Images. Worldwide, 2% to 12% of people diagnosed with type 2 diabetes have latent autoimmune diabetes in adulthood (LADA). A 41-year-old Hispanic woman presents to her worksite clinic ...
Clinical studies remain one of the most difficult phases in medical device development. They’re slow, expensive, and sometimes unpredictable — but completely necessary for nearly everything that ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced the start of GMP ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
LEXINGTON, Mass. and AMSTERDAM, May 29, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback